These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 668793)

  • 21. A new antipyretic agent.
    Weiss CF; Harris ST
    Mich Med; 1967 Nov; 66(21):1429-30. PubMed ID: 6062511
    [No Abstract]   [Full Text] [Related]  

  • 22. Capillary isotachophoretic determination of flufenamic, mefenamic, niflumic and tolfenamic acid in pharmaceuticals.
    Polásek M; Pospísilová M; Urbánek M
    J Pharm Biomed Anal; 2000 Aug; 23(1):135-42. PubMed ID: 10898163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flufenamic and tolfenamic acids and lemakalim relax guinea-pig isolated trachea by different mechanisms.
    Li L; Vapaatalo H; Vaali K; Paakkari I; Kankaanranta H
    Life Sci; 1998; 62(20):PL 303-8. PubMed ID: 9600333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-inflammatory, antipyretic and antinociceptive properties of N-(2,3-xylyl)anthranilic acid (mefenamic acid).
    WINDER CV; WAX J; SCOTTI L; SCHERRER RA; JONES EM; SHORT FW
    J Pharmacol Exp Ther; 1962 Dec; 138():405-13. PubMed ID: 14001132
    [No Abstract]   [Full Text] [Related]  

  • 25. Spectrofluorimetric determination of anthranilic acid derivatives based on terbium sensitized fluorescence.
    Ioannou PC; Rusakova NV; Andrikopoulou DA; Glynou KM; Tzompanaki GM
    Analyst; 1998 Dec; 123(12):2839-43. PubMed ID: 10435348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tolfenamic acid. Detection and structure of urinary metabolites.
    Pedersen SB; Alhede B; Buchardt O; Møller J; Bock K
    Arzneimittelforschung; 1981; 31(11):1944-8. PubMed ID: 7198475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antipyretic therapy.
    Elizabeth KE
    Indian Pediatr; 1997 Aug; 34(8):750. PubMed ID: 9492411
    [No Abstract]   [Full Text] [Related]  

  • 28. Anti-inflammatory and antipyretic properties of N-(alpha,alpha,alpha-trifluoro-m-tolyl) anthranilic acid (CI-440; flufenamic acid).
    WINDER CV; WAX J; SERRANO B; JONES EM; McPHEE ML
    Arthritis Rheum; 1963 Feb; 6():36-47. PubMed ID: 14001133
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of K(+) channel inhibitors on relaxation induced by flufenamic and tolfenamic acids in guinea-pig trachea.
    Li L; Vaali K; Vapaatalo H; Kankaanranta H
    Eur J Pharmacol; 1999 Oct; 383(2):169-76. PubMed ID: 10585531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of mefenamic acid and flufenamic acid on plasma uric acid levels.
    Latham BA; Radcliff F; Robinson RG
    Ann Phys Med; 1966 Aug; 8(7):242-3. PubMed ID: 5918265
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of the effects of fenamates on Ca-activated chloride and potassium currents in rabbit portal vein smooth muscle cells.
    Greenwood IA; Large WA
    Br J Pharmacol; 1995 Dec; 116(7):2939-48. PubMed ID: 8680728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antipyretic activity of mefenamic acid. Double-blind clinical studies in comparison with amidopyrine and a placebo].
    Porro A
    Minerva Med; 1971 Oct; 62(79):3786-90. PubMed ID: 4950071
    [No Abstract]   [Full Text] [Related]  

  • 33. 50 Years Ago in The Journal of Pediatrics: Mefenamic Acid: An Antipyretic for Use in Children.
    Dewan P; Gupta P
    J Pediatr; 2018 Jul; 198():66. PubMed ID: 29936973
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of non-steroidal anti-inflammatory drugs on polymorphonuclear leukocyte functions in vitro: focus on fenamates.
    Kankaanranta H; Moilanen E; Vapaatalo H
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Dec; 350(6):685-91. PubMed ID: 7708126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mefanamic acid--an antipyretic for use in children.
    Weiss CF; Harris ST; Barrow WB; Buchanan RA
    J Pediatr; 1968 Jun; 72(6):867-70. PubMed ID: 5652617
    [No Abstract]   [Full Text] [Related]  

  • 36. [On various derivatives of mefenamic and flufenamic acids].
    Spanò R; Marri R
    Boll Chim Farm; 1968 Aug; 107(8):512-5. PubMed ID: 5721222
    [No Abstract]   [Full Text] [Related]  

  • 37. Primary dysmenorrhoea and flufenamates.
    N Z Med J; 1978 May; 87(611):322. PubMed ID: 276706
    [No Abstract]   [Full Text] [Related]  

  • 38. The place of mefenamic acid in the treatment of rheumatoid arthritis.
    Mavrikakis ME; Madkour MM; Buchanan WW
    Scott Med J; 1978 Apr; 23(2):189-90. PubMed ID: 306128
    [No Abstract]   [Full Text] [Related]  

  • 39. New drugs. VII. A controlled trial of flufenamic acid therapy in rheumatoid arthritis.
    Fearnley ME; Masheter HC
    Ann Phys Med; 1966 May; 8(6):204-7. PubMed ID: 5937787
    [No Abstract]   [Full Text] [Related]  

  • 40. The Antipyretic Effect of High-Dose Paracetamol Versus Mefenamic Acid in the Treatment of Febrile Children: A Randomized Control Trial.
    Loya A; Siddiqui MS; Sangle A; Ingale V; Saha S; Nelanuthala M
    Cureus; 2022 Jul; 14(7):e26733. PubMed ID: 35967183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.